Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study

Michael P. Manns, Edward Gane, Maribel Rodriguez-Torres, Albrecht Stoehr, Chau Ting Yeh, Patrick Marcellin, Richard T. Wiedmann, Peggy M. Hwang, Luzelena Caro, Richard J.O. Barnard, Andrew W. Lee, Yacov Baruch, Yves Benhamou, Matthew Cave, Gary Davis, Shaban Faruqui, Michael Fried, Eliot Godofsky, Michael Gschwantler, Markus HeimMing Yang Lai, Eric Lawitz, Yoav Lurie, Darius Moradpour, Beat Müllhaupt, Francesco Negro, Court Pedersen, Ramón Planas Vila, Mark Russo, Rifaat Safadi, Alejandro Soza, Ulrich Spengler, Rudolf Stauber, Petr Urbanek, Elena Volchkova, Miroslava Volfova, Stefan Zeuzem

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint Dive into the research topics of 'Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences